Abstract

Background. The mechanisms responsible for the antihypertensive effect of selective imidazoline receptor agonists, such as rilmedinine, remain nowadays inadequately explored, improved baroreflectory regulation of the circulatory system in the treatment with antihypertensive drugs makes additional advantages in predicting further progression in patients with hypertensive disease. Aim. To estimate the time course of changes in the vasomotor component of cardiopulmonary baroreflex (CPBR) during acute and chronic therapy with rilmenidine versus atenolol and to study the impact of baroreflectory regulation on the efficiency of further therapy. Results. According to the data of daily monitoring, long-term therapy showed a significant decrease in blood pressure in both groups. Two hours after the use of rilmenidine, the patients showed a heterodirectional changes in the vasomotor component of CPBR whose variability was associated with the efficiency of further 6-month therapy with this drug, which was evaluated by the decrease of the level and variability of the diurnal blood pressure profile, and by the fattens recovery.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.